Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Aug 28, 2012 02:11 PM

Start: Nov 15, 2012 05:15 PM

[image reference is broken]

Speaker: Immaculada Martinez - Partner, Opus Corporate Finance LLP
Inma Martinez is a serial entrepreneur, investor, and corporate advisor. Considered by FORTUNE and TIME one of the world’s leading digital media strategists, she is currently a partner at Opus Corporate Finance LLP, a leading corporate finance advisory firm providing independent, strategic and creative advice primarily to UK and European mid-market businesses.

She is also a recognised commentator in the media on the digitalisation of work and life and the luxury industry.